Send a comment on this item to LII:
Send a comment on this item to LII staff, who on weekdays will usually reply within 24 hours.
FDA Asks Attention-Deficit Hyperactivity Disorder (ADHD) Drug Manufacturers to Develop Patient Medication Guide
Documents related to the Federal Drug Administration (FDA) directive in 2006 to "manufacturers of all drug products approved for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) to develop patient Medication Guides to alert patients to possible cardiovascular risks and risks of adverse psychiatric symptoms associated with the medicines, and to advise them of precautions that can be taken." Provides medication guides and labels for specific drugs, press release, and FDA committee transcripts.
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm107918.htm
Asterisk
*
indicates required field.
Your Name
Your Email Address
*
We will not sell or provide your email address to anyone else.
Comment
*
Enter the verification code as it is shown in the box below. This helps prevent automated submissions.
*
